PDSB

PDS BiotechnologyA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$1.75

+146.1% vs current

Most likely

Base case

45%

Probability

Target price

$0.85

+19.5% vs current

B-

Bear case

30%

Probability

Target price

$0.30

-57.8% vs current

AI sentiment snapshot

Latest data as of 2026-07-14

AI commentary

Coverage is low and mostly recap-oriented. News tone is mildly positive around the protocol redesign, but financing sensitivity and the absence of verified analyst revisions keep the setup in monitoring territory. No usable social, options, short-interest, or employee-sentiment data were provided.

RankAlpha Sentiment Codex - 2026-07-14

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-10-12eventVERSATILE-003 restart under amended Phase 3 designHigh impact

The amended protocol adds progression-free survival as an interim primary endpoint, preserves overall survival for full approval, reduces enrollment, and is intended to support a potential accelerated-approval path. Actual site reactivation and enrollment restart remain the key execution checks [#SEC-8K-2026-05-13].

2026-10-12catalystFinancing terms and dilution overhangHigh impact

The June 15 8-K references purchase-agreement and transaction documents incorporated from a prior filing. Because the packet does not include the full terms, dilution, warrant, and liquidity sensitivity remain unresolved [#8-K-2026-06-15].

2026-12-31catalystPDS01ADC colorectal cancer follow-upHigh impact

Stage 1 mCRC data showed a 77.8% six-month objective response rate and approximately 85% 24-month survival, with enrollment completed. Additional data are expected by year-end, but the dataset remains early and small [#SEC-8K-2026-05-13] [#PR-EARNINGS-2026-05-14].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-14 • Updated nightlySource: Internal modelMethodology